Harvard Bioscience (HBIO) EBITDA Margin (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,286.00 |
| Dec 31, 2025 | 625.00 |
| Sep 30, 2025 | 496.00 |
| Jun 30, 2025 | 22,410.00 |
| Mar 31, 2025 | -22,815.00 |
| Dec 31, 2024 | 857.00 |
| Sep 30, 2024 | 43.00 |
| Jun 30, 2024 | 34.00 |
| Mar 31, 2024 | -1,030.00 |
| Dec 31, 2023 | 468.00 |
| Sep 30, 2023 | -645.00 |
| Jun 30, 2023 | -307.00 |
| Mar 31, 2023 | 744.00 |
| Dec 31, 2022 | 1,237.00 |
| Sep 30, 2022 | -2,766.00 |
| Jun 30, 2022 | 3,701.00 |
| Mar 31, 2022 | -2,846.00 |
| Dec 31, 2021 | 329.00 |
| Sep 30, 2021 | 165.00 |
| Jun 30, 2021 | 108.00 |